Analytical Data
-
基因名
SLC25A35
- Application
-
别名
SLC25A35; Solute carrier family 25 member 35
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q3KQZ1
-
表达区间
1-291 aa
-
氨基酸序列
MDFLMSGLAACGACVFTNPLEVVKTRMQLQGELQAPGTYQRHYRNVFHAFITIGKVDGLAALQKGLAPALLYQFLMNGIRLGTYGLAEAGGYLHTAEGTHSPARSAAAGAMAGVMGAYLGSPIYMVKTHLQAQAASEIAVGHQYKHQGMFQALTEIGQKHGLVGLWRGALGGLPRVIVGSSTQLCTFSSTKDLLSQWEIFPPQSWKLALVAAMMSGIAVVLAMAPFDVACTRLYNQPTDAQGKGLMYRGILDALLQTARTEGIFGMYKEPSPQVLSNIMQCFSAFTGDQRC
-
分子量
57.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human SCARA3 Protein，His
Cat：PA1000-7657
Recombinant Human SCARA5 Protein，His
Cat：PA1000-7656
Protein Description
SLC25A35, a member of the SLC25 family of mitochondrial transporters, has been gaining attention in biological research due to its role in cellular metabolism and mitochondrial function. This protein is predominantly involved in the transport of specific metabolites across the mitochondrial inner membrane, which is crucial for maintaining cellular energy homeostasis. Recent studies suggest that SLC25A35 may play a significant role in various physiological processes, including fatty acid metabolism, oxidative stress responses, and regulation of apoptosis. Altered expression or mutation of the SLC25A35 gene has been linked to various metabolic disorders and diseases, highlighting its potential as a therapeutic target. Despite its importance, the structural and functional properties of SLC25A35 remain poorly characterized, necessitating further investigation. The development of recombinant SLC25A35 protein will provide valuable insights into its biochemical mechanisms and enhance our understanding of its role in human health and disease. This research could pave the way for targeted treatments in metabolic disorders associated with mitochondrial dysfunction, making SLC25A35 a critical focus for ongoing scientific exploration.
